Becton, Dickinson and Company (LON:0R19)
194.41
+1.63 (0.85%)
At close: Aug 13, 2025
LON:0R19 Revenue
Becton, Dickinson and Company had revenue of $5.51B USD in the quarter ending June 30, 2025, with 10.40% growth. This brings the company's revenue in the last twelve months to $21.39B, up 7.86% year-over-year. In the fiscal year ending September 30, 2024, Becton, Dickinson and Company had annual revenue of $20.18B with 4.16% growth.
Revenue (ttm)
$21.39B
Revenue Growth
+7.86%
P/S Ratio
2.65
Revenue / Employee
$289.00K
Employees
74,000
Market Cap
41.39B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 20.18B | 806.00M | 4.16% |
Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
Sep 30, 2021 | 19.13B | 3.06B | 19.02% |
Sep 30, 2020 | 16.07B | -1.22B | -7.03% |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
Oxford Nanopore Technologies | 183.19M |
HUTCHMED (China) | 439.54M |
Becton, Dickinson and Company News
- 22 days ago - BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs - PRNewsWire
- 22 days ago - BD Board Declares Dividend - PRNewsWire
- 23 days ago - Best Dividend Kings: July 2025 - Seeking Alpha
- 25 days ago - Schlumberger, Stellantis And ASML Holding Are Among Top 10 Large Cap Losers Last Week (July 14-July 18): Are The Others In Your Portfolio? - Benzinga
- 4 weeks ago - WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT - Business Wire
- 4 weeks ago - How Do Investors Really Feel About Becton Dickinson? - Benzinga
- 4 weeks ago - Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks - The Wall Street Journal
- 4 weeks ago - Waters downgraded at Wells Fargo after Becton, Dickinson deal - Seeking Alpha